#National Institute of Allergy and Infectious Diseases

With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.

Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.

Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

A statement from the National Institutes of Health on World AIDS Day 2017.

The study of a vaccine that is designed to prevent multiple strains of the virus will include 2,600 women in sub-Saharan Africa.

Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.

HIV scientists and advocates are waging a powerful war against the global epidemic.

A new HIV vaccine regimen was well tolerated and elicited a good immune response among participants of a study who did not have the virus.

A 9-year-old South African child infected with HIV at birth has been in an apparent state of extended viral remission.

Researchers found a way to block a protein linked with blood clotting and inflammatory processes using a drug derived from tick saliva.

Gazing into the crystal ball at the epidemic’s future reveals many exciting advancements. Lower infection rates is just the beginning.

Plus: This timeline of HIV vaccine research includes today’s HVTN 702 trial—the first new major trial in seven years.

For the first time, a major clinical trial has found that starting antiretroviral treatment soon after HIV diagnosis reduces the risk of sickn...

Researchers have mapped the development of a key HIV antibody, establishing scientific knowhow that may aid in the development of a vaccine.

A major trial has closed down after the experimental vaccine failed both to prevent HIV transmission and to reduce viral load in those who con...

How pharmaceutical and biotech companies are playing a major role in the search for an HIV cure.